SanofiSNYNASDAQ
Loading
Revenue PerformanceStable
Percentile Rank100
3Y CAGR+4.8%
5Y CAGR+4.6%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+4.8%/yr
vs +3.3%/yr prior
5Y CAGR
+4.6%/yr
Consistent
Acceleration
+1.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
5 yr
Consecutive growthStable
PeriodValueYoY Change
2025$46.72B+5.5%
2024$44.29B+6.4%
2023$41.62B+2.6%
2022$40.56B+3.5%
2021$39.17B+4.8%
2020$37.37B-0.7%
2019$37.63B+5.5%
2018$35.68B-1.5%
2017$36.22B+4.4%
2016$34.70B-